Skip to main content

Robotics in Neurorehabilitation: Beyond the Hype—Understanding What It Can (and Cannot) Do

Dr. Rishabh Pathak
Over the past decade, robotic neurorehabilitation has become one of the most discussed innovations in neurological recovery. Robotic gait trainers, upper-limb rehabilitation systems, exoskeletons, and AI-assisted rehabilitation devices are increasingly being adopted by hospitals and rehabilitation centres worldwide. However, an important question remains: Are robots the future of neurorehabilitation—or are they simply another tool in the rehabilitation toolbox? As clinicians and researchers, we must move beyond marketing claims and focus on scientific evidence, patient selection, and clinical reasoning. What is Robotic Neurorehabilitation? Robotic neurorehabilitation involves the use of electromechanical devices that assist, guide, resist, or augment movement during therapy. These technologies include: • Robotic gait trainers • Wearable exoskeletons • Upper limb robotic rehabilitation devices • End-effector robotic systems • Sensor-based rehabilitation platforms • AI-assiste...
Post a Comment

From Basic Mechanisms to Therapeutic Targets in Huntington's Disease

Image
Dr. Rishabh Pathak

Huntington's disease (HD) is a devastating neurodegenerative disorder characterized by motor dysfunction, cognitive decline, and psychiatric symptoms. Understanding the basic mechanisms underlying HD pathology has led to the identification of potential therapeutic targets aimed at slowing disease progression and improving patient outcomes. Here is an overview of the journey from basic mechanisms to therapeutic targets in Huntington's disease:


1.      Basic Mechanisms of Huntington's Disease:

o    CAG Repeat Expansion: HD is primarily caused by an abnormal expansion of CAG repeats in the huntingtin (HTT) gene, leading to the production of mutant huntingtin protein (mHTT) with toxic properties.

o  Protein Aggregation: mHTT forms aggregates within neurons, disrupting cellular functions, impairing proteostasis, and triggering neurotoxicity.

o    Mitochondrial Dysfunction: HD is associated with mitochondrial abnormalities, including impaired energy metabolism, oxidative stress, and mitochondrial fragmentation, contributing to neuronal dysfunction and degeneration.

o Excitotoxicity and Calcium Dysregulation: Dysregulation of calcium homeostasis and excitotoxicity play a role in neuronal death in HD, leading to synaptic dysfunction and neurodegeneration.

2.     Therapeutic Targets in Huntington's Disease:

o    Targeting Protein Aggregation:

§  HSP90 Inhibition: Heat shock protein 90 (HSP90) inhibitors have shown promise in reducing mHTT aggregation and promoting protein clearance mechanisms [T11].

§Autophagy Modulation: Enhancing autophagy pathways through mTOR inhibition or activation of autophagy regulators can facilitate the clearance of mHTT aggregates and improve neuronal survival [T12].

o    Mitochondrial Protection:

§  Mitochondrial Biogenesis: Activating pathways involved in mitochondrial biogenesis, such as PGC-1α, can enhance mitochondrial function and protect neurons from HD-related mitochondrial dysfunction [T13].

§Antioxidant Therapy: Targeting oxidative stress with antioxidants or mitochondrial-targeted compounds may mitigate mitochondrial damage and reduce neuronal vulnerability in HD [T14].

o    Excitotoxicity and Calcium Regulation:

§  NMDA Receptor Modulation: NMDA receptor antagonists or modulators can help regulate calcium influx and excitotoxic signaling pathways implicated in HD pathogenesis [T15].

§  Calcium Channel Blockers: Inhibiting calcium channels or modulating calcium-binding proteins may offer neuroprotection by restoring calcium homeostasis in HD-affected neurons [T16].

3.     Emerging Therapeutic Strategies:

o Gene Silencing: RNA interference (RNAi) or antisense oligonucleotide (ASO) therapies targeting mHTT mRNA have shown potential for reducing mutant huntingtin levels and ameliorating HD symptoms [T17].

o  Epigenetic Modulation: HDAC inhibitors and other epigenetic modifiers are being explored for their ability to regulate gene expression, chromatin remodeling, and neuroprotection in HD [T18].

o    Neuroinflammation Targeting: Modulating neuroinflammatory responses through microglial activation inhibitors or anti-inflammatory agents may help mitigate neurodegeneration and disease progression in HD [T19].

In conclusion, the transition from understanding the basic mechanisms of Huntington's disease to identifying therapeutic targets has paved the way for the development of innovative treatment strategies aimed at addressing key pathological processes underlying HD. By targeting protein aggregation, mitochondrial dysfunction, excitotoxicity, and other disease mechanisms, researchers and clinicians are working towards improving outcomes for individuals affected by Huntington's disease.

 

Categories:

Comments

Post a Comment

Popular posts from this blog

Electrode Artifacts Compared to Focal Interictal Epileptiform Discharge

Dr. Rishabh Pathak
Electrode artifacts and focal interictal epileptiform discharges (IEDs) are distinct patterns that can be observed in EEG recordings.  1.      Electrode Artifacts : o Description : Electrode artifacts are typically caused by various factors such as electrode pops, poor electrode contact, electrode/lead movement, perspiration artifacts, salt bridge artifacts, or patient movements. o   Characteristics : These artifacts manifest as brief transients limited to specific electrode channels or low-frequency rhythms across scalp regions, often lacking a plausible cerebral source. o Localization : Electrode artifacts are usually confined to the channels of one electrode and do not exhibit a field indicating a gradual decrease in potential amplitude across the scalp. o Waveform : Electrode artifacts, like electrode pops, have distinct waveforms with rapid rises and slower falls, differentiating them from genuine brain activity. 2.    Focal Interictal Epilep...
Post a Comment
Read more

Myelogenesis (Formation of Myelin)

Dr. Rishabh Pathak
Myelogenesis, the process of myelin formation in the central nervous system, is a crucial aspect of brain development that enhances neural communication, accelerates signal conduction, and supports cognitive functions. Here is an overview of myelogenesis in the context of brain development: 1.      Definition : o     Myelogenesis refers to the development and maturation of myelin, a fatty substance that forms an insulating sheath around axons in the central nervous system, including the brain and spinal cord. o   Myelin sheaths are produced by specialized glial cells called oligodendrocytes in the central nervous system, which wrap around axons to facilitate rapid and efficient transmission of electrical impulses. 2.      Key Aspects of Myelogenesis : o     Myelin Sheath Formation : During myelogenesis, oligodendrocytes extend processes to wrap around axons, forming multiple layers of myelin sheaths that insulate...
Post a Comment
Read more

How Brain Computer Interface is working in the Neurosurgery ?

Dr. Rishabh Pathak
Brain-Computer Interfaces (BCIs) have profound implications in the field of neurosurgery, providing innovative tools for monitoring brain activity, aiding surgical procedures, and facilitating rehabilitation. 1. Overview of BCIs in Neurosurgery BCIs in neurosurgery aim to create a direct communication pathway between the brain and external devices, which can be utilized for various surgical applications. These interfaces can aid in precise surgery, enhance patient outcomes, and provide feedback on brain function during operations. 2. Mechanisms of BCIs in Neurosurgery 2.1 Types of BCIs Invasive BCIs : These involve implanting devices directly into the brain tissue, providing high-resolution data. Invasive BCIs, such as electrocorticography (ECoG) grids, are often used intraoperatively for detailed monitoring of brain activity. Non-invasive BCIs : Primarily utilize EEG and fNIRS. They are helpful for pre-operative assessments and monitoring post-operati...
Post a Comment
Read more

What is Brain Network Modulation?

Dr. Rishabh Pathak
Brain network modulation refers to the process of influencing or altering the connectivity and activity patterns within the brain's functional networks. Here are some key points about brain network modulation:   1. Definition:    - Brain network modulation involves interventions or treatments that target specific brain regions or networks to induce changes in their functional connectivity, activity levels, or communication patterns.    - The goal of brain network modulation is to restore or optimize the balance and coordination of neural activity within and between different brain regions, ultimately leading to improved cognitive or behavioral outcomes.   2. Therapeutic Interventions:    - Various therapeutic interventions, such as pharmacotherapy, psychotherapy, neuromodulation techniques (e.g., transcranial magnetic stimulation, deep brain stimulation), and lifestyle interventions (e.g., exercise, mindfulness practices), can modula...
Post a Comment
Read more

Cell Maturation (Dendrite and Axon Growth)

Dr. Rishabh Pathak
Cell maturation, encompassing dendrite and axon growth, is a crucial stage of brain development where neurons undergo structural changes to establish connections and form functional neural circuits. Here is an overview of cell maturation in the context of dendrite and axon growth: 1.      Dendrite Growth : o     Definition : Dendrites are branched extensions of a neuron that receive signals from other neurons and transmit these signals to the cell body. o     Dendritic Arborization : During maturation, neurons extend and elaborate their dendritic arbors, increasing the surface area available for synaptic connections. o     Synaptic Integration : Dendritic growth is essential for forming synapses with other neurons, allowing for the integration of incoming signals and information processing. o     Activity-Dependent Plasticity : Dendritic growth can be influenced by neural activity and sensory experiences, sh...
Post a Comment
Read more